Home/ Supplements/ Huperzine A/ NeuPerzine

NeuPerzine

product on market Capsule Biotics Research Corporation Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for NeuPerzine
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 0.15mg (41 products)

Other Ingredients

Microcrystalline Cellulose capsule shell Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

RECOMMENDATION: One (1) capsule taken one (1) to two (2) times each day as a dietary supplement or as otherwise directed by a healthcare professional.

Warnings & Precautions

Caution: Not recommended for pregnant or lactating women.

Not intended for prolonged use or for those with urinary retention due to obstruction and respiratory related conditions.

KEEP OUT OF REACH OF CHILDREN

Sealed with an imprinted safety seal for your protection.

Additional Information

Store in a cool, dry area.

Rev. 06/11

{recycle} Please Recycle

Metadata

Product Details

DSLD Entry Date2013-06-25
Product TypeBotanical
FormCapsule
DSLD ID22090
Data Updated2026-04-11
Research

Research Evidence

2
Research Sources
64
Avg Quality
2
Cochrane Review
B Huperzine A for vascular dementia.
Cochrane Review The Cochrane database of systematic reviews PubMed DOI
B Huperzine A for mild cognitive impairment.
Cochrane Review The Cochrane database of systematic reviews PubMed DOI
View all evidence for Huperzine A →
Compare

Similar Products

View all Huperzine A products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.